MedTrace Logo

Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

NCT01612390 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2012-06-05

No results posted yet for this study

Summary

Sublingual misoprostol is superior to oxytocin in reduction of blood loss during the third and fourth stages of labor

Conditions

  • Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Rasha Mohammed Mohammed Badawi

    lead OTHER

Principal Investigators

  • RBadawi mohamed, M.B;B.CH · Ain Shams University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-08-31
Completion
2013-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612390 on ClinicalTrials.gov